Biogen (BIIB): are the analysts right?

Biogen · Health Care · ref. ETF XLV · 123 calls · price $205.7
What the company does: Biogen développe et commercialise des thérapies médicales.
📈 1-year price
$205.7+53.0% over range
Jul 8, 25low $122.68 · high $216.63Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
55% recommend buying · 20 analysts

🎯 Analyst price target on BIIB

High target · 1 analyst$275+33.7%
Median target · 19 analysts$224+8.9%
Low target · 1 analyst$150-27.1%
Current price$205.7

🗳️ The analyst consensus

Analyst breakdown · 20 (6 months)
Strong Buy0%
Buy55%
Hold40%
Sell5%
Strong Sell0%

✅ Historical analyst reliability on BIIB

Most reliable analysts on BIIB (% profitable · 365j · ≥2 calls)
RBC Capital 42% +3.7% 12
Canaccord Genuity 33% -1.6% 12
HC Wainwright & Co. 25% -6.4% 12
Morgan Stanley 8% -14.1% 12
Oppenheimer 8% -26.7% 12
Needham 0% -33.5% 12

📊 What $1,000 invested in Biogen would be worth

In short — $1,000 invested in Biogen 10 years ago would be worth $705 today, i.e. -3%/yr on average. Best year: 2022 (+15%), worst: 2024 (-41%). Price performance, excluding dividends.

If I'd invested $1,000 in Biogen

InvestmentWorth todayGain
1 years ago$1,413+41%
3 years ago$780-22%
5 years ago$882-12%
10 years ago$705-29%
since inception (1991)$70,074+6907%

Return by year (Biogen)

YearReturn$1,000 invested at year start
2026 (YTD)+23%$1,228 (+23%)
2025+15%$1,413 (+41%)
2024-41%$835 (-17%)
2023-7%$780 (-22%)
2022+15%$901 (-10%)
2021-2%$882 (-12%)
2020-17%$728 (-27%)
2019-1%$718 (-28%)
2018-6%$678 (-32%)
2017+12%$762 (-24%)
2016-7%$705 (-29%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on BIIB

RBC Capital
Jul 7, 26
▲ Outperform · 🎯$242
Today : $205.7 — upside +18%
🎯 on BIIB : 42% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Jul 7, 27
Needham
Jun 29, 26
▲ Buy · 🎯$256
Price at call : $216.63 — upside +18%
Today : $205.7 — upside +24%
🎯 on BIIB : 0% (12 calls matureds) · 📊 on Health : 51% · +4.4% (153 calls)
in progress (365j)
matures : Jun 29, 27
■ Equal-Weight neutral · not a buy · 🎯$224
Price at call : $196.58 — gap to target +14%
Today : $205.7 — gap to target +9%
🎯 on BIIB : 8% (12 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Jun 18, 27
Mizuho
Jun 15, 26
▲ Outperform · 🎯$221
Price at call : $195.61 — upside +13%
Today : $205.7 — upside +7%
🎯 on BIIB : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)
in progress (365j)
matures : Jun 15, 27
Needham
Jun 8, 26
▲ Buy · 🎯$255
Price at call : $192.62 — upside +32%
Today : $205.7 — upside +24%
🎯 on BIIB : 0% (12 calls matureds) · 📊 on Health : 51% · +4.4% (153 calls)
in progress (365j)
matures : Jun 8, 27
RBC Capital
May 27, 26
▲ Outperform · 🎯$227
Price at call : $196.39 — upside +16%
Today : $205.7 — upside +10%
🎯 on BIIB : 42% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : May 27, 27
Piper Sandler
May 15, 26
▲ Overweight · 🎯$225
Price at call : $191.91 — upside +17%
Today : $205.7 — upside +9%
🎯 on BIIB : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : May 15, 27
Citigroup
May 1, 26
■ Neutral neutral · not a buy · 🎯$200
Price at call : $187.21 — gap to target +7%
Today : $205.7 — gap to target -3%
🎯 on BIIB : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : May 1, 27
■ Equal-Weight neutral · not a buy · 🎯$206
Price at call : $187.06 — gap to target +10%
Today : $205.7 — gap to target +0%
🎯 on BIIB : 8% (12 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Apr 30, 27
RBC Capital
Apr 30, 26
▲ Outperform · 🎯$222
Price at call : $187.06 — upside +19%
Today : $205.7 — upside +8%
🎯 on BIIB : 42% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Apr 30, 27
Guggenheim
Apr 30, 26
▲ Buy · 🎯$260
Price at call : $187.06 — upside +39%
Today : $205.7 — upside +26%
🎯 on BIIB : no call matured yet · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : Apr 30, 27
Wedbush
Apr 30, 26
■ Neutral neutral · not a buy · 🎯$196
Price at call : $189.28 — gap to target +4%
Today : $205.7 — gap to target -5%
🎯 on BIIB : no call matured yet · 📊 on Health : 42.9% · -6.3% (7 calls)
in progress (365j)
matures : Apr 30, 27
UBS
Apr 22, 26
▲ Buy · 🎯$225
Price at call : $190.07 — upside +18%
Today : $205.7 — upside +9%
🎯 on BIIB : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Apr 22, 27
Wells Fargo
Apr 20, 26
▲ Overweight · 🎯$250
Price at call : $185.95 — upside +34%
Today : $205.7 — upside +22%
🎯 on BIIB : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Apr 20, 27
Piper Sandler
Apr 14, 26
▲ Overweight · 🎯$214
Price at call : $178.96 — upside +20%
Today : $205.7 — upside +4%
🎯 on BIIB : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Apr 14, 27
Citigroup
Apr 13, 26
■ Neutral neutral · not a buy · 🎯$190
Price at call : $178.96 — gap to target +6%
Today : $205.7 — gap to target -8%
🎯 on BIIB : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Apr 13, 27
■ Hold neutral · not a buy · 🎯$189
Price at call : $178.96 — gap to target +6%
Today : $205.7 — gap to target -8%
🎯 on BIIB : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Apr 13, 27
■ Equal-Weight neutral · not a buy · 🎯$200
Price at call : $176.37 — gap to target +13%
Today : $205.7 — gap to target -3%
🎯 on BIIB : 8% (12 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Apr 10, 27
▲ Buy · 🎯$237
Price at call : $177.34 — upside +34%
Today : $205.7 — upside +15%
🎯 on BIIB : 25% (12 calls matureds) · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : Apr 2, 27
▲ Buy · 🎯$245
Price at call : $177.34 — upside +38%
Today : $205.7 — upside +19%
🎯 on BIIB : 33% (12 calls matureds) · 📊 on Health : 54.1% · +6.8% (148 calls)
in progress (365j)
matures : Apr 1, 27
Oppenheimer
Apr 1, 26
▲ Outperform · 🎯$275
Price at call : $177.34 — upside +55%
Today : $205.7 — upside +34%
🎯 on BIIB : 8% (12 calls matureds) · 📊 on Health : 43.5% · -0.4% (216 calls)
in progress (365j)
matures : Apr 1, 27
HSBC
Mar 17, 26
▼ Reduce · 🎯$150
Price at call : $182.31 — upside -18%
Today : $205.7 — upside -27%
🎯 on BIIB : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Mar 17, 27
Freedom Broker
Feb 23, 26
■ Hold neutral · not a buy · 🎯$185
Price at call : $196.34 — gap to target -6%
Today : $205.7 — gap to target -10%
🎯 on BIIB : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 23, 27
Barclays
Feb 20, 26
■ Equal-Weight neutral · not a buy · 🎯$185
Price at call : $196.34 — gap to target -6%
Today : $205.7 — gap to target -10%
🎯 on BIIB : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Feb 20, 27
Wedbush
Feb 10, 26
■ Neutral neutral · not a buy · 🎯$187
Price at call : $191.2 — gap to target -2%
Today : $205.7 — gap to target -9%
🎯 on BIIB : no call matured yet · 📊 on Health : 42.9% · -6.3% (7 calls)
in progress (365j)
matures : Feb 10, 27
JP Morgan
Feb 9, 26
■ Neutral neutral · not a buy · 🎯$230
Price at call : $188.99 — gap to target +22%
Today : $205.7 — gap to target +12%
🎯 on BIIB : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Feb 9, 27
▲ Buy · 🎯$230
Price at call : $188.99 — upside +22%
Today : $205.7 — upside +12%
🎯 on BIIB : 33% (12 calls matureds) · 📊 on Health : 54.1% · +6.8% (148 calls)
in progress (365j)
matures : Feb 9, 27
BMO Capital
Feb 9, 26
■ Market Perform neutral · not a buy · 🎯$196
Price at call : $188.99 — gap to target +4%
Today : $205.7 — gap to target -5%
🎯 on BIIB : no call matured yet · 📊 on Health : 60.9% · +9.2% (235 calls)
in progress (365j)
matures : Feb 9, 27
TD Cowen
Feb 9, 26
▲ Buy · 🎯$215
Price at call : $188.99 — upside +14%
Today : $205.7 — upside +5%
🎯 on BIIB : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Feb 9, 27
Citigroup
Feb 9, 26
■ Neutral neutral · not a buy · 🎯$215
Price at call : $188.99 — gap to target +14%
Today : $205.7 — gap to target +5%
🎯 on BIIB : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Feb 9, 27
RBC Capital
Feb 9, 26
▲ Outperform · 🎯$233
Price at call : $188.99 — upside +23%
Today : $205.7 — upside +13%
🎯 on BIIB : 42% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Feb 9, 27
Guggenheim
Feb 9, 26
▲ Buy · 🎯$246
Price at call : $188.99 — upside +30%
Today : $205.7 — upside +20%
🎯 on BIIB : no call matured yet · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : Feb 9, 27
Wells Fargo
Feb 9, 26
■ Equal-Weight neutral · not a buy · 🎯$200
Price at call : $193.81 — gap to target +3%
Today : $205.7 — gap to target -3%
🎯 on BIIB : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Feb 9, 27
■ Hold neutral · not a buy · 🎯$193
Price at call : $193.81 — gap to target -0%
Today : $205.7 — gap to target -6%
🎯 on BIIB : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Feb 9, 27
Wedbush
Feb 9, 26
■ Neutral neutral · not a buy · 🎯$187
Price at call : $193.81 — gap to target -4%
Today : $205.7 — gap to target -9%
🎯 on BIIB : no call matured yet · 📊 on Health : 42.9% · -6.3% (7 calls)
in progress (365j)
matures : Feb 9, 27
▲ Buy · 🎯$228
Price at call : $193.81 — upside +18%
Today : $205.7 — upside +11%
🎯 on BIIB : 25% (12 calls matureds) · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : Feb 9, 27
■ Neutral neutral · not a buy · 🎯$177
Price at call : $193.81 — gap to target -9%
Today : $205.7 — gap to target -14%
🎯 on BIIB : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Feb 9, 27
Oppenheimer
Jan 30, 26
▲ Outperform · 🎯$225
Price at call : $179.09 — upside +26%
Today : $205.7 — upside +9%
🎯 on BIIB : 8% (12 calls matureds) · 📊 on Health : 43.5% · -0.4% (216 calls)
in progress (365j)
matures : Jan 30, 27
Citigroup
Jan 27, 26
■ Neutral neutral · not a buy · 🎯$185
Price at call : $174.83 — gap to target +6%
Today : $205.7 — gap to target -10%
🎯 on BIIB : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Jan 27, 27
■ Hold neutral · not a buy · 🎯$190
Price at call : $187.62 — gap to target +1%
Today : $205.7 — gap to target -8%
🎯 on BIIB : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Jan 8, 27
Citigroup
Jan 7, 26
■ Neutral neutral · not a buy · 🎯$180
Price at call : $186 — gap to target -3%
Today : $205.7 — gap to target -12%
🎯 on BIIB : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Jan 7, 27
■ Equal-Weight neutral · not a buy · 🎯$156
Price at call : $175.74 — gap to target -11%
Today : $205.7 — gap to target -24%
🎯 on BIIB : 8% (12 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Dec 12, 26
Wells Fargo
Dec 10, 25
■ Equal-Weight neutral · not a buy · 🎯$190
Price at call : $172.5 — gap to target +10%
Today : $205.7 — gap to target -8%
🎯 on BIIB : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Dec 10, 26
HSBC
Dec 10, 25
▼ Reduce · 🎯$143
Price at call : $177.55 — upside -19%
Today : $205.7 — upside -30%
🎯 on BIIB : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Dec 10, 26
Piper Sandler
Nov 21, 25
■ Neutral neutral · not a buy · 🎯$157
Price at call : $176.82 — gap to target -11%
Today : $205.7 — gap to target -24%
🎯 on BIIB : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Nov 21, 26
■ Hold neutral · not a buy
🎯 on BIIB : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Nov 6, 26
Stifel
Nov 6, 25
▲ Buy · 🎯$202
Price at call : $156.74 — upside +29%
Today : $205.7 — upside -2%
🎯 on BIIB : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Nov 6, 26
Bernstein
Nov 3, 25
■ Market Perform neutral · not a buy · 🎯$157
Price at call : $151.44 — gap to target +4%
Today : $205.7 — gap to target -24%
🎯 on BIIB : no call matured yet · 📊 on Health : 55.6% · +5.7% (63 calls)
in progress (365j)
matures : Nov 3, 26
RBC Capital
Oct 31, 25
▲ Outperform · 🎯$210
Price at call : $151.44 — upside +39%
Today : $205.7 — upside +2%
🎯 on BIIB : 42% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Oct 31, 26
Citigroup
Oct 14, 25
■ Neutral neutral · not a buy · 🎯$153
Price at call : $143.66 — gap to target +7%
Today : $205.7 — gap to target -26%
🎯 on BIIB : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Oct 14, 26
▲ Buy · 🎯$194
Price at call : $131.95 — upside +47%
Today : $205.7 — upside -6%
🎯 on BIIB : 25% (12 calls matureds) · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : Aug 1, 26
RBC Capital
Jun 27, 25
▲ Outperform · 🎯$213
Price at call : $126.08 — upside +69%
Today : $205.7 — upside +4%
Expected +69% · Actual +72% · Reason (≥ +15%) : ✓ Yes
🎯 on BIIB : 42% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
+71.8%
stock +72% · XLV +20%
▲ Buy · 🎯$187
Price at call : $126.92 — upside +47%
Today : $205.7 — upside -9%
Expected +47% · Actual +70% · Reason (≥ +15%) : ✓ Yes
🎯 on BIIB : 25% (12 calls matureds) · 📊 on Health : 51% · +0.6% (51 calls)
+70.2%
stock +70% · XLV +19%
RBC Capital
Jun 25, 25
▲ Outperform · 🎯$213
Price at call : $126.92 — upside +68%
Today : $205.7 — upside +4%
Expected +68% · Actual +70% · Reason (≥ +15%) : ✓ Yes
🎯 on BIIB : 42% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
+70.2%
stock +70% · XLV +19%
RBC Capital
May 2, 25
▲ Outperform · 🎯$205
Price at call : $121.8 — upside +68%
Today : $205.7 — upside -0%
Expected +68% · Actual +54% · Reason (≥ +15%) : ✓ Yes
🎯 on BIIB : 42% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
+53.7%
stock +54% · XLV +5%
▲ Buy · 🎯$220
Price at call : $121.8 — upside +81%
Today : $205.7 — upside +7%
Expected +81% · Actual +54% · Reason (≥ +15%) : ✓ Yes
🎯 on BIIB : 33% (12 calls matureds) · 📊 on Health : 54.1% · +6.8% (148 calls)
+53.7%
stock +54% · XLV +5%
▲ Buy · 🎯$187
Price at call : $123.53 — upside +51%
Today : $205.7 — upside -9%
Expected +51% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on BIIB : 25% (12 calls matureds) · 📊 on Health : 51% · +0.6% (51 calls)
+51.5%
stock +52% · XLV +4%
RBC Capital
Apr 22, 25
▲ Outperform · 🎯$225
Price at call : $118.17 — upside +90%
Today : $205.7 — upside +9%
Expected +90% · Actual +59% · Reason (≥ +15%) : ✓ Yes
🎯 on BIIB : 42% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
+59.0%
stock +59% · XLV +8%
RBC Capital
Feb 13, 25
▲ Outperform · 🎯$225
Price at call : $137.33 — upside +64%
Today : $205.7 — upside +9%
Expected +64% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on BIIB : 42% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
+42.4%
stock +42% · XLV +9%
▲ Buy · 🎯$241
Price at call : $138.45 — upside +74%
Today : $205.7 — upside +17%
Expected +74% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on BIIB : 25% (12 calls matureds) · 📊 on Health : 51% · +0.6% (51 calls)
+41.9%
stock +42% · XLV +8%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)